☰

Empresas y finanzas

Gilead Sciences to Release Fourth Quarter and Year End 2006 Financial Results on Wednesday, January 31, 2007


    Gilead Sciences, Inc. (Nasdaq:GILD) announced today that its
    fourth quarter and year end 2006 financial results will be released on
    Wednesday, January 31, 2007, at 4:00 p.m. Eastern Time. At 4:30 p.m.
    Eastern Time, Gilead will webcast a conference call live on the
    company's internet site. The call will be led by John Martin, PhD,
    President and Chief Executive Officer; John Milligan, PhD, Executive
    Vice President and Chief Financial Officer; Norbert Bischofberger,
    PhD, Executive Vice President, Research and Development; and Kevin
    Young, Executive Vice President, Commercial Operations. Gilead
    management will discuss the company's fourth quarter and year end 2006
    results, provide an overview of the company, and an outlook and
    financial guidance for 2007.

    To access the webcast via the internet, log on to www.gilead.com.
    Please connect to the company's website at least 15 minutes prior to
    the conference call to ensure adequate time for any software download
    that may be needed to hear the webcast. Alternatively, please call
    1-800-901-5259 (U.S.) or 1-617-786-4514 (international) and dial the
    participant passcode 19934233 to access the call. Telephone replay is
    available approximately two hours after the call through 4:00 p.m.
    Eastern Time, February 2, 2007. To access, please call 1-888-286-8010
    (U.S.) or 1-617-801-6888 (international) and dial the participant
    passcode 79206534. The webcast will be archived on www.gilead.com for
    one year.

    About Gilead

    Gilead Sciences is a biopharmaceutical company that discovers,
    develops and commercializes innovative therapeutics in areas of unmet
    medical need. The company's mission is to advance the care of patients
    suffering from life-threatening diseases worldwide. Headquartered in
    Foster City, California, Gilead has operations in North America,
    Europe and Australia.

    For more information on Gilead Sciences, please visit
    www.gilead.com or call the Gilead Public Affairs Department at
    1-800-GILEAD-5 (1-800-445-3235).